Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

See all formats and pricing
In This Section
Volume 44, Issue 3 (Mar 2006)


Urinary cystatin C as a specific marker of tubular dysfunction

Marc Conti
  • Biochemistry Laboratory, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France
/ Stéphane Moutereau
  • Biochemistry & Genetics Department, AP-HP Mondor University Hospital, Créteil, France
/ Mokhtar Zater
  • Biochemistry Laboratory, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France
/ Karim Lallali
  • Biochemistry Laboratory, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France
/ Antoine Durrbach
  • Nephrology Department, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France
/ Philippe Manivet
  • Biochemistry Laboratory, AP-HP Lariboisière University Hospital, Paris, France
/ Pascal Eschwège
  • Urology Departments, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France and Antony Private Hospital, Antony, France
/ Sylvain Loric
  • Nephrology Department, AP-HP Bicêtre University Hospital, Le Kremlin-Bicêtre, France
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2006.050


Background: Cystatin C (CST3), a strong inhibitor of cysteine proteinases, is freely filtered by the kidney glomerulus and is reabsorbed by the tubules, where it is almost totally catabolized, with the remainder then eliminated in urine. In tubular diseases, it seems sensible to postulate that CST3 degradation would be reduced and consequently an increase in its urinary elimination would be observed.

Methods: We report here the development of an automatic quantitative assay to measure CST3 concentrations in urine using a Behring N-Latex Cystatin C kit on a BNII laser nephelometer. We tested its clinical relevance on several kidney disease patients.

Results: This assay is sensitive (limit of detection 0.008mg/L) and precise (within- and between-day CVs <4%). Reference values for freshly collected urine samples range from 0.03 to 0.18mg/L. Mean urine CST3 concentrations obtained from 52 patients with kidney tubular disease (4.31±3.85mg/L) were significantly higher than those for 60 controls (0.096±0.044mg/L; p<0.0001) and 47 glomerular disease patients (0.106±0.133mg/L; p<0.0001).

Conclusion: Increased urinary CST3 concentrations allow the accurate detection of tubular dysfunction among pure and mixed nephropathies. Because of its ability to be processed on automated clinical chemistry analyzers, this assay could easily be used as an adjunct to the standard panel used to screen kidney pathologies, even in emergency situations.

Keywords: cystatin C; kidney; tubular marker; tubulopathy; urine


  • 1.

    Turk B, Turk V, Turk D. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997; 378:141–50.

  • 2.

    Barrett AJ. The cystatins: small protein inhibitors of cysteine proteinases. Prog Clin Biol Res 1985; 180:105–16.

  • 3.

    Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 1997; 173:423–32.

  • 4.

    Grubb A, Lofberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982; 79:3024–7. [Crossref]

  • 5.

    Lofberg H, Grubb A, Davidsson L, Kjellander B, Stromblad LG, Tibblin S, et al. Occurrence of gamma-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma. Acta Endocrinol (Copenh) 1983; 104:69–76.

  • 6.

    Lofberg H, Nilsson KE, Stromblad LG, Lasson A, Olsson SO. Demonstration of gamma-trace in normal endocrine cells of the adrenal medulla and in phaeochromocytoma. An immunohistochemical study in monkey, dog and man. Acta Endocrinol (Copenh) 1982; 100:595–8.

  • 7.

    Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37:49–59. [Crossref]

  • 8.

    Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001; 39:850–7. [Crossref]

  • 9.

    Christensson A, Ekberg J, Grubb A, Ekberg H, Lindstrom V, Lilja H. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol 2003; 94:19–27. [Crossref]

  • 10.

    Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38(Suppl 1):S20–7.

  • 11.

    Grubb AO. Cystatin C – properties and use as diagnostic marker. Adv Clin Chem 2000; 35:63–99.

  • 12.

    Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48:699–707.

  • 13.

    Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999; 14:1991–6.

  • 14.

    Risch L, Huber AR. Assessing the diagnostic accuracy of cystatin C as a marker of impaired glomerular filtration rate. Am J Kidney Dis 2002; 39:661–2. [Crossref]

  • 15.

    Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995; 26:559–64. [Crossref]

  • 16.

    Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002; 323:121–8.

  • 17.

    Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004; 10:476–82. [Crossref]

  • 18.

    Tencer J, Thysell H, Andersson K, Grubb A. Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at –20°C. Scand J Urol Nephrol 1997; 31:67–71.

  • 19.

    Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43:1016–22.

  • 20.

    Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob HG, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50:552–8. [Crossref]

  • 21.

    Lofberg H, Grubb AO. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39:619–26. [Crossref]

  • 22.

    Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994; 66:453–8. [Crossref]

  • 23.

    Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol 2004; 19:1278–80. [Crossref]

  • 24.

    Hosaka B, Park SI, Felipe CR, Garcia RG, Machado PG, Pereira AB, et al. Predictive value of urinary retinol binding protein for graft dysfunction after kidney transplantation. Transplant Proc 2003; 35:1341–3. [Crossref]

  • 25.

    Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43:405–14. [Crossref]

  • 26.

    Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231–8.

  • 27.

    Conti M, Zater M, Lallali K, Durrbach A, Moutereau S, Manivet P, et al. Absence of circadian variations in urine cystatin C allows its use on urinary samples. Clin Chem 2005; 51:272–3. [Crossref]

About the article

Corresponding author: Prof. Sylvain Loric, Laboratoire de Biochimie et Génétique, CHU Henri Mondor de Créteil, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil cedex, France Phone: +33-1-49812847, Fax: +33-1-49812842,

Received: 2005-10-11

Accepted: 2005-12-16

Published Online: 2011-09-21

Published in Print: 2006-03-01

Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.050. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Puddu Melania, Podda Maria Francesca, Mussap Michele, Tumbarello Roberto, and Fanos Vassilios
The Journal of Maternal-Fetal & Neonatal Medicine, 2009, Volume 22, Number 2, Page 83
Rakhi Maiwall and Richard Moreau
Current Hepatology Reports, 2016
Maria de Fátima Castro Mendes, João Victor Salgado, José de Ribamar Lima, Teresa Cristina Alves Ferreira, Gyl Eanes Barros Silva, and Natalino Salgado Filho
Clinical Biochemistry, 2015, Volume 48, Number 7-8, Page 546
Harald Mischak, Christian Delles, Antonia Vlahou, and Raymond Vanholder
Nature Reviews Nephrology, 2015, Volume 11, Number 4, Page 221
Vikas Garg, Manish Kumar, Himansu Sekhar Mahapatra, Anubhuti Chitkara, Adesh Kumar Gadpayle, and Venketansan Sekhar
Clinical and Experimental Nephrology, 2015
J.D. García-Martínez, S. Martinez-Subiela, A. Tvarijonaviciute, M. Caldin, and J.J. Ceron
Research in Veterinary Science, 2015, Volume 99, Page 204
Konstantinos M. Pirgakis, Konstantinos Makris, Ilias Dalainas, Andreas M. Lazaris, Chrisostomos K. Maltezos, and Christos D. Liapis
Annals of Vascular Surgery, 2014, Volume 28, Number 7, Page 1649
L. Ghys, D. Paepe, P. Smets, H. Lefebvre, J. Delanghe, and S. Daminet
Journal of Veterinary Internal Medicine, 2014, Volume 28, Number 4, Page 1152
Mamta Padhy, Smita Kaushik, M.P. Girish, Sudhesna Mohapatra, Seema Shah, and Bidhan Chandra Koner
Clinica Chimica Acta, 2014, Volume 435, Page 48
Liesbeth F. E. Ghys, Evelyne Meyer, Dominique Paepe, Joris Delanghe, and Sylvie Daminet
Veterinary Clinical Pathology, 2014, Volume 43, Number 2, Page 226
Karen Tan and Sunil K. Sethi
Translational Research, 2014, Volume 164, Number 2, Page 122
Johanna Helmersson-Karlqvist, Johan Ärnlöv, Axel C. Carlsson, Johan Härmä, and Anders Larsson
Atherosclerosis, 2014, Volume 234, Number 1, Page 108
J. De Loor, S. Daminet, P. Smets, B. Maddens, and E. Meyer
Journal of Veterinary Internal Medicine, 2013, Volume 27, Number 5, Page 998
Zohra Ghlissi, Ahmed Hakim, Hela Mnif, Fatma Makni Ayadi, Khaled Zeghal, Tarak Rebai, and Zouheir Sahnoun
Renal Failure, 2013, Volume 35, Number 8, Page 1130
Stelios Kokkoris, Chrysoula Pipili, Eirini Grapsa, Theodoros Kyprianou, and Serafim Nanas
Renal Failure, 2013, Volume 35, Number 4, Page 579
Evdoxia Tsigou, Vasiliki Psallida, Christos Demponeras, Eleni Boutzouka, and George Baltopoulos
Critical Care Research and Practice, 2013, Volume 2013, Page 1
So-Jung Sohn, Sun Young Kim, Hyung Sik Kim, Young-Jin Chun, Soon Young Han, Seung Hee Kim, and Aree Moon
Toxicology Letters, 2013, Volume 217, Number 3, Page 235
Uwe Christians, Jost Klawitter, Jelena Klawitter, Nina Brunner, and Volker Schmitz
Expert Opinion on Drug Metabolism & Toxicology, 2011, Volume 7, Number 2, Page 175
David Schnell, Stéphane Deruddre, Anatole Harrois, Julien Pottecher, Claudine Cosson, Nadir Adoui, Dan Benhamou, Eric Vicaut, Elie Azoulay, and Jacques Duranteau
Shock, 2012, Volume 38, Number 6, Page 592
Xiaochun Zhang, Bill Gibson, Ryan Mori, Devon Snow-Lisy, Yuka Yamaguchi, Steven C. Campbell, Matthew N. Simmons, and Thomas M. Daly
Clinica Chimica Acta, 2013, Volume 415, Page 88
Hong-Guang Xie, Shu-Kui Wang, Chang-Chun Cao, and Ernie Harpur
Pharmacology & Therapeutics, 2013, Volume 137, Number 1, Page 100
Feria Hikmet Noraddin, Mats Flodin, Annika Fredricsson, Azita Sohrabian, and Anders Larsson
Journal of Clinical Laboratory Analysis, 2012, Volume 26, Number 5, Page 358
P. Monti, G. Benchekroun, D. Berlato, and J. Archer
Journal of Small Animal Practice, 2012, Volume 53, Number 5, Page 254
Yanhong Li, Chenlu Fu, Xiaofei Zhou, Zhihui Xiao, Xueming Zhu, Meifang Jin, Xiaozhong Li, and Xing Feng
Pediatric Nephrology, 2012, Volume 27, Number 5, Page 851
Tobias Christian Fuchs and Philip Hewitt
Biomarkers in Medicine, 2011, Volume 5, Number 6, Page 763
Azita Sohrabian, Feria Hikmet Noraddin, Mats Flodin, Annika Fredricsson, and Anders Larsson
Clinical Biochemistry, 2012, Volume 45, Number 4-5, Page 339
Tobias Christian Fuchs and Philip Hewitt
The AAPS Journal, 2011, Volume 13, Number 4, Page 615
Stefan Herget-Rosenthal, Joanna A.E. van Wijk, Martina Bröcker-Preuss, and Arend Bökenkamp
Clinical Biochemistry, 2007, Volume 40, Number 13-14, Page 946
Bart Cortjens, Annick A.N.M. Royakkers, Rogier M. Determann, Jeroen D.E. van Suijlen, Stephan S. Kamphuis, Jannetje Foppen, Anita de Boer, Cathrien.W. Wieland, Peter E. Spronk, Marcus J. Schultz, and Catherine S.C. Bouman
Journal of Critical Care, 2012, Volume 27, Number 3, Page 261
Jeffrey C. Sirota, Jelena Klawitter, and Charles L. Edelstein
Journal of Toxicology, 2011, Volume 2011, Page 1
Lesley A. Inker and Aghogho Okparavero
Current Opinion in Nephrology and Hypertension, 2011, Volume 20, Number 6, Page 631
Michael A. Ferguson, Vishal S. Vaidya, and Joseph V. Bonventre
Toxicology, 2008, Volume 245, Number 3, Page 182
Vishal S. Vaidya, Michael A. Ferguson, and Joseph V. Bonventre
Annual Review of Pharmacology and Toxicology, 2008, Volume 48, Number 1, Page 463
Marc Conti, Stéphane Moutereau, Liliane Esmilaire, Cédric Desbene, Karim Lallali, Michel Devanlay, Antoine Durrbach, Philippe Manivet, Pascal Eschwège, and Sylvain Loric
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 12
Mitchell H Rosner
Biomarkers in Medicine, 2008, Volume 2, Number 1, Page 55
Annick A. N. M. Royakkers, Johanna C. Korevaar, Jeroen D. E. van Suijlen, Lieuwe S. Hofstra, Michael A. Kuiper, Peter E. Spronk, Marcus J. Schultz, and Catherine S. C. Bouman
Intensive Care Medicine, 2011, Volume 37, Number 3, Page 493
Frank Dieterle, Elias Perentes, André Cordier, Daniel R Roth, Pablo Verdes, Olivier Grenet, Serafino Pantano, Pierre Moulin, Daniel Wahl, Andreas Mahl, Peter End, Frank Staedtler, François Legay, Kevin Carl, David Laurie, Salah-Dine Chibout, Jacky Vonderscher, and Gérard Maurer
Nature Biotechnology, 2010, Volume 28, Number 5, Page 463
Qing-Run Li, Ke-Xin Fan, Rong-Xia Li, Jie Dai, Chao-Chao Wu, Shi-Lin Zhao, Jia-Rui Wu, Chia-Hui Shieh, and Rong Zeng
Rapid Communications in Mass Spectrometry, 2010, Volume 24, Number 6, Page 823
Shamik H Shah and Ravindra L Mehta
Current Opinion in Nephrology and Hypertension, 2006, Volume 15, Number 6, Page 561
Michael Darmon, Frédérique Schortgen, Rusel Leon, Stéphane Moutereau, Julien Mayaux, Fabiano Di Marco, Jérôme Devaquet, Christian Brun-Buisson, and Laurent Brochard
Intensive Care Medicine, 2009, Volume 35, Number 6, Page 1031
Acil Jaafar, Sophie Séronie-Vivien, Laurence Malard, Patrice Massip, Etienne Chatelut, and Ivan Tack
AIDS, 2009, Volume 23, Number 2, Page 257
Sophie Séronie-Vivien, Pierre Delanaye, Laurence Piéroni, Christophe Mariat, Marc Froissart, and Jean-Paul Cristol
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 12
Vishal S. Vaidya, Sushrut S. Waikar, Michael A. Ferguson, Fitz B. Collings, Kelsey Sunderland, Costas Gioules, Gary Bradwin, Roland Matsouaka, Rebecca A. Betensky, Gary C. Curhan, and Joseph V. Bonventre
Clinical and Translational Science, 2008, Volume 1, Number 3, Page 200
Vishal S Vaidya and Joseph V Bonventre
Expert Opinion on Drug Metabolism & Toxicology, 2006, Volume 2, Number 5, Page 697

Comments (0)

Please log in or register to comment.
Log in